Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine Plus Bupivacaine for Postoperative Pain in Hemorrhoid Surgery
NCT07442539Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Intravenous Morphine Equivalents at 48 hours. Started Mar 2026; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07442539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07442539.